Janus kinase (JAK) inhibitors are associated with decreased mortality and fewer serious adverse events among adults hospitalized with COVID-19.

Pemivibart was well tolerated and prophylactic against COVID-19 infection among adult patients with significant immunocompromising conditions.

Paxlovid is an antiviral combination therapy that can reduce the risk of COVID-19 causing severe illness, hospitalization and ...

No improvement in clinical outcomes occurred among inpatients with COVID-19 who received nirtmatrelvir-ritonavir or molnupiravir in addition to usual care.

Paloma Shemirani, 23, died at Royal Sussex County Hospital on July 24 2024 after declining treatment for non-Hodgkin lymphoma ...

The data from this prospective cohort study confirm and expand previous retrospective case series that have found factors, including hematologic cancers, chemotherapy receipt, and lung cancer, as ...

Despite offering significant protection against severe COVID-19, patients with cancer, a high-risk group, showed low uptake of booster vaccinations.

Air Force Reserve Maj. Gen. John Bartrum has a long history of working in military and public health positions, including the ...

A woman who died after refusing chemotherapy was having "five coffee enemas a day" under her mother's care, her brother told ...

The 65-year-old man died in a post-operative complication after his airway was blocked following the spinal surgery.

COVID-19 activity is yet again on the rise in Hawaii, according to the latest report from the Hawaii Department of Health.